z-logo
Premium
Optimized CRISPR/Cas9 strategy for homology‐directed multiple targeted integration of transgenes in CHO cells
Author(s) -
Shin Sung Wook,
Lee Jae Seong
Publication year - 2020
Publication title -
biotechnology and bioengineering
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.136
H-Index - 189
eISSN - 1097-0290
pISSN - 0006-3592
DOI - 10.1002/bit.27315
Subject(s) - crispr , chinese hamster ovary cell , cas9 , plasmid , computational biology , transgene , genome editing , biology , genome engineering , guide rna , template , cell culture , dna , genetics , gene , nanotechnology , materials science
Site‐specific integration has emerged as a promising strategy for precise Chinese hamster ovary (CHO) cell line engineering and predictable cell line development (CLD). CRISPR/Cas9 with the homology‐directed repair (HDR) pathway enables precise integration of transgenes into target genomic sites. However, inherent recalcitrance to HDR‐mediated targeted integration (TI) of transgenes results in low targeting efficiency, thus requiring a selection process to find a targeted integrant in CHO cells. Here, we explored several parameters that influence the targeting efficiency using a promoter‐trap‐based single‐ or double‐knock‐in (KI) monitoring system. A simple change in the donor template design by the addition of single‐guide RNA recognition sequences strongly increased KI efficiency (2.9–36.0 fold), depending on integration sites and cell culture mode, compared to conventional circular donor plasmids. Furthermore, sequential and simultaneous KI strategies enabled us to obtain populations with ~1–4% of double‐KI cells without additional enrichment procedures. Thus, this simple optimized strategy not only allows efficient CRISPR/Cas9‐mediated TI in CHO cells but also paves the way for the applicability of multiplexed KIs in one experimental step without the need for sequential and independent CHO–CLD procedures.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here